TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.72
-0.01 (-0.17%)
Apr 28, 2025, 4:00 PM EDT - Market closed
TriSalus Life Sciences Employees
TriSalus Life Sciences had 110 employees as of December 31, 2024. The number of employees decreased by 2 or -1.79% compared to the previous year.
Employees
110
Change (1Y)
-2
Growth (1Y)
-1.79%
Revenue / Employee
$267,555
Profits / Employee
-$302,118
Market Cap
184.60M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 110 | -2 | -1.79% |
Dec 31, 2023 | 112 | 37 | 49.33% |
Dec 31, 2022 | 75 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TLSI News
- 4 weeks ago - TriSalus Life Sciences: Optimistic Guidance For 2025, But There Are Still Risks - Seeking Alpha
- 4 weeks ago - TriSalus Life Sciences, Inc. (TLSI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping - Business Wire
- 7 weeks ago - TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model” - Business Wire
- 3 months ago - TriSalus Life Sciences Announces Key Appointments to Board of Directors - Business Wire
- 3 months ago - TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed - Business Wire
- 3 months ago - TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call - Business Wire